İdiyopatik Ani Sensörinöral İşitme Kayıplı Erişkin Hastalarda Komorbid Durumların Prognoz Üzerine Etkisi

Öz

ÖZ Amaç: Tip 2 diabetes mellitus (DM) ve primer (esansiyel) hipertansiyon (HT) hastalıklarının idiyopatik ani sensörinöral işitme kaybı (İASİK) prognozu üzerindeki etkilerini belirlemek. Gereç ve Yöntemler: Kliniğimizde, 1 Ocak 2017- 31 Aralık 2019 tarihleri arasında İASİK tanısı ile tedavi edilen 160 hastanın kayıtları, hastane bilgi sistemi üzerinden retrospektif olarak incelendi. Hastalar, komorbidite varlığına göre dört gruba ayrıldı: kontrol grubu, DM grubu, HT grubu ve DM + HT grubu. Prognoz değerlendirmesinde Siegel kriterleri kullanıldı. Bulgular: Siegel kriterlerine göre, kontrol grubu ile diğer gruplar arasında iyileşme düzeyleri açısından anlamlı bir fark saptanmadı. Gruplar arasında işitme kazançları açısından da istatistiksel olarak anlamlı bir fark bulunmadı. Ancak, komorbid hastalıkları bulunan hasta gruplarında tedavi öncesi işitme eşik değerleri kontrol grubuna kıyasla anlamlı olarak daha yüksek bulundu ve bu fark tedavi sonrası nihai işitme eşik değerlerinde de devam etti. Sonuçlar: Tip 2 diabetes mellitus ve esansiyel hipertansiyon tanılı İASİK hastalarında tedavi sonrası işitme kazançları ve iyileşme düzeyleri, komorbiditesi bulunmayan hasta grubu ile benzerdir. Bununla birlikte, bu hastaların tedavi başlangıcındaki ve sonundaki işitme eşik değerleri, komorbiditesi bulunmayan hastalara kıyasla anlamlı derecede yüksektir. Anahtar Kelimeler: Esansiyel hipertansiyon, Ani işitme kaybı, Tip 2 diabetes mellitus

Anahtar Kelimeler

• Esansiyel hipertansiyon
• ani işitme kaybı
• tip 2 diabetes mellitus

Effect of Comorbid Conditions on Prognosis in Adult Patients with Idiopathic Sudden Sensorineural Hearing Loss

Abstract

ABSTRACT Objective: To determine the effects of type 2 diabetes mellitus (DM) and primary (essential) hypertension (HT) on the prognosis of idiopathic sudden sensorineural hearing loss (ISSNHL). Materials and Methods: Medical records of 160 patients treated with ISSNHL at our clinic between January 1, 2017, and December 31, 2019, were retrospectively reviewed using the hospital information system. Patients were categorized into four groups based on the presence or absence of comorbid conditions: control group, DM, HT, and both DM and HT. Prognosis was evaluated using Siegel’s criteria. Results: According to Siegel’s criteria, there was no statistically significant difference in recovery rates or hearing gains between the control group and the comorbidity groups. However, both the initial and final hearing threshold levels were significantly higher in patients with comorbidities compared to the control group. Conclusion: Hearing gains and recovery rates following treatment were comparable between patients with comorbidities (DM and/or HT) and those without. However, both the initial and final hearing thresholds were significantly elevated in the comorbidity groups. Keywords: Essential hypertension, Sudden hearing loss, Type 2 diabetes mellitus

Keywords

• essential hypertension
• sudden hearing loss
• type 2 diabetes mellitus

Kaynakça

1. 1. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld, RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ. American Academy of Otolaryngology-Head and Neck Surgery Clinical practice guideline: sudden hearing loss. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012; 146(3 Suppl): S1–S35.
2. 2. Leong AC, Fairley JW, Padgham ND. Sudden hearing loss. Clin Otolaryngol 2007; 32(5):391-4.
3. 3. Leung MA , Flaherty A, Zhang JA, Hara J, Barber W, Burgess L. Sudden Sensorineural Hearing Loss: Primary Care Update. Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health 2016; 75(6):172–4.
4. 4. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977; 86(4 Pt 1):463-80.
5. 5. Edizer DT, Çelebi Ö, Hamit B, Baki A, Yiğit Ö. Recovery of Idiopathic Sudden Sensorineural Hearing Loss. J Int Adv Otol 2015; 11(2):122-6.
6. 6. Kuhn M, Heman-Ackah SE, Shaikh JA, Roehm PC. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011; 15(3):91-105.
7. 7. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984; 94(5 Pt 1):664-6.
8. 8. Aimoni C , Bianchini C, Borin M, Ciorba A, Fellin R, Martini A, Scanelli G, Volpato S. Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study. Audiology & neuro-otology 2010; 15(2):111–5.

9. 9. Weng SF, Chen YS, Hsu CJ, Tseng FY. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005; 115(9):1676-80.
10. 10. Ceylan A , Çelenk F, Kemaloğlu YK, Bayazit YA, Göksu N, Özbilen S. Impact of prognostic factors on recovery from sudden hearing loss. The Journal of laryngology and otology 2007; 121(11): 1035–40.
11. 11. Ullrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992; 249(5):273-6.
12. 12. Narozny W , Kuczkowski J, Kot J, Stankiewicz C, Sicko Z, Mikaszewski B. Prognostic factors in sudden sensorineural hearing loss: our experience and a review of the literature. The Annals of otology, rhinology, and laryngology 2006; 115(7): 553–8.
13. 13. Xenellis J , Karapatsas I, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Tzagkaroulakis M, Ferekidis E. Idiopathic sudden sensorineural hearing loss: prognostic factors. The Journal of laryngology and otology 2006; 120(9): 718–24.
14. 14. Wen YH, Chen PR, Wu HP. Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2014; 271(6):1423-9.
15. 15. Kaplan Yunus, Ulkumen Burak, Kanlikama Muzaffer. Evaluation of prognostic factors in sudden hearing loss. The Journal of Kartal Training and Research Hospital 2012; 23: 84-90.
16. 16. Hirano K , Ikeda K, Kawase T, Oshima T, Kekehata S, Takahashi S, Sato T, Kobayashi T, Takasaka T. Prognosis of sudden deafness with special reference to risk factors of microvascular pathology. Auris, nasus, larynx 1999; 26(2): 111–5.
17. 17. Lin CF, Lee KJ, Yu SS, Lin YS. Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss. Laryngoscope 2016; 126(1):142-9.
18. 18. Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M et al. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 1994; 114(6):601-7.
19. 19. Pruszewicz A, Kruk-Zagajewska A, Szyfter W, Smolińska K. Lipid levels in patients with sudden deafness of unknown aetiology. Audiology 1983; 22(1):63-72.
20. 20. Duck SW, Prazma J, Bennett PS, Pillsbury HC. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope 1997; 107(12 Pt 1):1596-1605.
21. 21. Morizono T, Paparella MM. Hypercholesterolemia and auditory dysfunction. Experimental studies. Ann Otol Rhinol Laryngol 1978; 87(6 Pt 1):804-14.
22. 22. Chen YL, Ding YP. Relationship between hypertension and hearing disorders in the elderly. East Afr Med J 1999; 76(6):344-7.
23. 23. Seo HW, Chung JH, Byun H, Jeong JH, Lee SH. Effect of Diabetes on the Prognosis of Sudden Sensorineural Hearing Loss: Propensity Score Matching Analysis. Otolaryngol Head Neck Surg 2020; 162(3):346-52.